AGP Executive Report
Last update: 11 hours agoCBD & Sleep Trials: Avecho is set to release phase III insomnia results for its synthetic CBD therapy, with ~520 patients taking 75mg, 150mg, or placebo nightly for eight weeks, positioning the product for an OTC pathway. Legal & Policy Shockwaves: The US Supreme Court unanimously ruled that marijuana users can’t be barred from owning guns just for using cannabis, a major Second Amendment win that’s already reshaping how states and regulators talk about cannabis. Ghana Hemp Licensing: Ghana’s industrial hemp fees and stalled licensing are headed to court, with critics calling the charges unscaled and exclusionary, while NACOC arrests on campus have reignited stigma concerns amid unfinished rules. Product & Retail Safety: Baguio’s “drug-cleared” barangay status was revoked after THC-laced vapes were reportedly found in schools, underscoring ongoing enforcement pressure around cannabis products. Industry Moves: Vape-Jet relocated its cannabis automation HQ, engineering, and manufacturing to Pittsburgh’s Strip District, betting on growth in legal cannabis production tech. Enforcement & Crime: NSW police charged a western Sydney teacher over alleged child abuse material found on devices, alongside a small amount of cannabis found in his car.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
